乙醇诱导的老鼠快速眼动睡眠抑制:与亚型选择性GABAA受体化合物的比较
Jaren A Reeves-Darby1,2, Lais F Berro1,2,3, Heather L Hembree1
1Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA.
Journal of psychopharmacology (Oxford, England)
|June 20, 2025
概括
乙醇和特定的GABAA受体化合物减少REM睡眠. 这项研究表明,各种GABAAR亚型介导着乙醇.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 酒精使用障碍与睡眠障碍有关,包括减少眼睛快速运动 (REM) 睡眠.
- 乙醇对睡眠的影响背后的精确药理机制在很大程度上是未知的.
研究的目的:
- 研究GABAA受体 (GABAAR) 亚型在乙醇诱导的睡眠改变中的作用.
- 为了比较乙醇和亚型选择性GABAAR化合物的对睡眠-清醒状态和EEG光谱功率的影响.
主要方法:
- 向斯普拉格-道利大鼠注射乙醇或选择性GABAAR亚型化合物.
- 12小时的脑电图 (EEG) 和肌电图 (EMG) 记录.
- 睡眠-觉醒状态和EEG光谱功率的分析.
主要成果:
- 乙醇,阿尔普拉佐拉姆,皮,KRM-II-81和MP-III-022降低了REM睡眠时间.
- 加博沙多尔 (α4/6-选择性) 增加了慢波睡眠 (SWS).
- 脑电图谱功率分析显示,每个化合物都有独特的特征,没有一个符合乙醇的特征.
结论:
- 含GABAARs的α1,α2,α3和/或α5亚单元的正调节可以抑制REM睡眠,这可能解释了乙醇的作用.
- 含有α4/6亚单元的GABAARs可能会导致乙醇诱导的SWS增加.
- 独特的EEG光谱功率特征表明,非GABAergic系统参与了乙醇的EEG效应.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
248
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
248
Sedatives and Hypnotics: Overview
695
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
695
Sedatives and Hypnotics Drugs: Benzodiazepines
399
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
399
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
CNS Depressants: Barbiturates and Benzodiazepines
484
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
484
Sedatives and Hypnotics Drugs: Barbiturates
510
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
510


